Anavex Life Sciences Corp (AVXL)

[Investor2014]

Not about winning, just the importance of proper use of terms and understanding how and when chances of success may be improved.

Of course if A2-73 works in any indication without resorting to patient selection for better trial response, that will be great.

If not, chances of success for the next trials may be improved if biomarkers will help select subgroups that responds better. Should that happen Anavex will be practicing Precision Medicine.

So far Anavex is not practicing Precision Medicine, but they are laying the basis for doing so based on potentially finding more biomarkers for patient selection.

How many angels can dance on the head of a pin, is always going to be a nonsensical question, whether practising Precision Medicine could improve trial succes is a real pursuit with real outcomes.